Tumor-Secreted microRNAs as Circulating Biomarkers for Lung Cancer Detection and Prognostic Stratification
Year: 2026
Type: article
Abstract: Background: Early lung cancer detection remains challenging. Low-dose CT screening reduces mortality but is limited by false positives and low uptake. Circulating miRNAs are stable blood biomarkers, but reproducibility is poor as most derive from non-tumor tissues. We hypothesized that miRNAs secreted by lung cancer cells would provide more grounded biomarkers. Methods: Small RNA sequencing was performed on paired intracellular and extracellular RNA from conditioned media of six NSCLC cell lines and non-malignant controls. Differentially expressed miRNAs enriched in cancer-derived fractions were identified. Candidates were validated in serum from NSCLC patients and controls by RT-qPCR and examined in TCGA cohorts. Pathway and survival analyses assessed relevance. Results: Extracellular miRNA profiles were conserved across NSCLC lines and distinct from intracellular profiles. A core set of 25 miRNAs was enriched in cancer-derived media. Five miRNAs (miR-10b, miR-25, miR-92a, miR-182, miR-375) were elevated in NSCLC serum and robustly expressed in TCGA tumors. Pathway analysis showed enrichment of PI3K–Akt and hypoxia signaling. Elevated miR-10b was associated with poorer survival. Conclusions: Lung cancer cells secrete a conserved miRNA set detectable in serum and tumors, linked to oncogenic pathways and survival. Cell-based profiling offers a strategy for developing plasma miRNA assays for lung cancer detection.
Source: Cancers
Institution: University of California San Diego
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7235124830
